Literature DB >> 35530651

Pre-operative Serum Albumin as a Potential Predictor of Benign Lesions in Renal Masses.

Sho Sekito1, Yuji Ogura1, Norihito Soga1, Takahiro Kojima1.   

Abstract

BACKGROUND/AIM: We investigated pre-operative factors for predicting whether renal masses are benign in order to facilitate the selection of optimal candidates for pre-operative biopsy. PATIENTS AND METHODS: We evaluated 278 patients with renal masses suspected to be clinically T1 or T2 renal cell carcinoma. All patients had undergone a partial or radical nephrectomy. Pre-operative parameters, including patient characteristics, tumor size, and blood tests, were utilized to predict which lesions were benign.
RESULTS: Twenty-five lesions (9.0%) were benign. Multivariate analysis showed that female sex [odds ratio (OR)=2.92, p=0.016], serum albumin ≥4.3 g/dl (OR=3.50, p=0.013), and tumor size <23 mm (OR=3.96, p=0.002) were significant independent factors for benign renal masses. The incidence of benign lesions in cases with all three factors (female sex, higher serum albumin, and smaller tumor size) was 4 of 16 (25.0%), which was significantly higher (p=0.037) than that in all cases (25/278; 9.0%).
CONCLUSION: Relatively high pre-operative serum albumin levels may be a predictor of benign lesions when associated with female sex and smaller tumor size. Copyright 2022, International Institute of Anticancer Research.

Entities:  

Keywords:  Predictive factors; benign renal tumor; malignant renal tumor; renal biopsy; serum albumin

Year:  2022        PMID: 35530651      PMCID: PMC9066531          DOI: 10.21873/cdp.10115

Source DB:  PubMed          Journal:  Cancer Diagn Progn        ISSN: 2732-7787


  25 in total

1.  Low incidence of benign lesions in resected suspicious renal masses greater than 2 cm: Single-center experience from Japan.

Authors:  Norihito Soga; Kouhei Nishikawa; Haruyuki Takaki; Yasushi Yamada; Kiminobu Arima; Norio Hayashi; Yoshiki Sugimura
Journal:  Int J Urol       Date:  2012-04-19       Impact factor: 3.369

2.  Declining incidence of benign lesions among small renal masses treated with surgery: Effect of diagnostic tests for characterization.

Authors:  Sangjun Yoo; Dalsan You; Cheryn Song; Bumsik Hong; Jun Hyuk Hong; Choung-Soo Kim; Hanjong Ahn; In Gab Jeong
Journal:  Urol Oncol       Date:  2018-06-01       Impact factor: 3.498

3.  Partial Nephrectomy for Presumed Renal-Cell Carcinoma: Incidence, Predictors, and Perioperative Outcomes of Benign Lesions.

Authors:  Tyler M Bauman; Aaron M Potretzke; Alec J Wright; Brent A Knight; Joel M Vetter; Robert Sherburne Figenshau
Journal:  J Endourol       Date:  2017-02-03       Impact factor: 2.942

4.  Role of MRI in indeterminate renal mass: diagnostic accuracy and impact on clinical decision making.

Authors:  Taekmin Kwon; In Gab Jeong; Sangjun Yoo; JungBok Lee; Sungwoo Hong; Dalsan You; Jun Hyuk Hong; Hanjong Ahn; Choung-Soo Kim
Journal:  Int Urol Nephrol       Date:  2015-02-14       Impact factor: 2.370

Review 5.  Percutaneous renal biopsy: approach, diagnostic accuracy and risks.

Authors:  Taylor Capretz; Roshan M Patel; Zhamshid Okhunov
Journal:  Curr Opin Urol       Date:  2018-07       Impact factor: 2.309

6.  Rising incidence of small renal masses: a need to reassess treatment effect.

Authors:  John M Hollingsworth; David C Miller; Stephanie Daignault; Brent K Hollenbeck
Journal:  J Natl Cancer Inst       Date:  2006-09-20       Impact factor: 13.506

Review 7.  Systemic inflammation, nutritional status and survival in patients with cancer.

Authors:  Donald C McMillan
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2009-05       Impact factor: 4.294

Review 8.  Role of systemic inflammatory response markers in urological malignancy.

Authors:  Yoshio Ohno
Journal:  Int J Urol       Date:  2018-09-25       Impact factor: 3.369

9.  Incidence and predictive factors of benign renal lesions in Korean patients with preoperative imaging diagnoses of renal cell carcinoma.

Authors:  Seo Yong Park; Seong Soo Jeon; Seo Yeon Lee; Byong Chang Jeong; Seong Il Seo; Hyun Moo Lee; Han Yong Choi
Journal:  J Korean Med Sci       Date:  2011-02-25       Impact factor: 2.153

10.  How to Select the Optimal Candidates for Renal Mass Biopsy.

Authors:  Alberto Martini; Alessandro Larcher; Carlo Andrea Bravi; Paolo Capogrosso; Ugo Giovanni Falagario; Giuseppe Fallara; Francesco Pellegrino; Fabio Muttin; Chiara Re; Alberto Briganti; Andrea Salonia; Roberto Bertini; Francesco Montorsi; Umberto Capitanio
Journal:  Eur Urol Oncol       Date:  2020-10-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.